Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study finds link between common neurological disorder and Alzheimer’s disease

22.08.2002


A new study by scientists at The Wistar Institute links the genes responsible for neurofibromatosis, a common neurological disorder, to a protein thought to play a role in Alzheimer’s disease.



In establishing a connection between the two diseases, the research opens new lines of thinking for investigators studying both diseases, while also providing basic biological insights into vital cellular processes. A report on the study was published electronically on August 20 in the Journal of Biological Chemistry.

The protein shared by neurofibromatosis and Alzheimer’s disease is kinesin-1, known to be pivotal to protein trafficking, which is the movement of various needed proteins from one part of a cell to another. Neurons are characterized by long arms called processes that extend away from the cell body, and under normal circumstances proteins move along a system of microtubules to reach all parts of the neuron. Problems with the internal transport of proteins can lead to neuronal malfunction and death.


"This protein, kinesin-1, is like a locomotive that pulls cargo throughout the cell," says Ramin Shiekhattar, Ph.D., an associate professor at The Wistar Institute and senior author on the study. "In neurons, it pulls its cargo down microtubules, which can be thought of like the rails for the locomotive. Kinesin-1 is vital for efficient protein trafficking within neurons and other cells, and it’s of great interest to us to find it linked to the genes that cause neurofibromatosis."

The two genes linked to the disease are among the most commonly mutated genes in the entire human genome. The primary neurofibromatosis-related gene, called NF1, or neurofibromin, was identified in the early 1990s by Francis S. Collins, M.D., Ph.D., now director of the National Human Genome Research Institute. Another less common gene linked to the same disorder is called NF2, or merlin. Since the discovery of these genes, however, most aspects of their activity in the body and in neurofibromatosis have remained a mystery.

Neurofibromatosis is a common disorder, more prevalent than cystic fibrosis, muscular dystrophy, Huntington’s disease, and Tay-Sachs disease combined. It can cause tumors along nerves throughout the body and can affect the development of non-nervous tissues such as bones and skin. The disease can also cause learning disabilities of differing severity. While most cases of neurofibromatosis are mild to moderate, it can lead to disfigurement, blindness, deafness, skeletal abnormalities, retardation, and tumors of the skin, spine, and brain.

In the current study, the Wistar researchers used the tools of biochemistry to identify distinct NF1- and NF2-containing protein complexes in the nucleus and the cytoplasm of cells. An analysis by mass spectrometry of the nuclear complex revealed four subunits, one of which was kinesin-1.

"Kinesin-1 is the real engine of this protein complex," Shiekhattar says.

Unrelated recent studies have also shown that kinesin-1 interacts with a protein called amyloid precursor protein, of APP, which has been implicated in Alzheimer’s disease, a major cause of dementia in older people.

"If kinesin-1 is the locomotive, then APP’s role appears to be to hook the cargo to the locomotive," Shiekhattar explains. "Finding kinesin-1 in protein complexes that also contain NF1 and NF2 clearly ties neurofibromatosis and Alzheimer’s disease to a common cellular pathway."


The lead author on the Journal of Biological Chemistry study is Mohamed-Ali Hakimi, Ph.D., at The Wistar Institute. Wistar professor David W. Speicher, Ph.D., collaborated on the study. This research was supported by grants from National Institutes of Health.

The Wistar Institute is an independent nonprofit biomedical research institution dedicated to discovering the causes and cures for major diseases, including cancer, cardiovascular disease, autoimmune disorders, and infectious diseases. Founded in 1892 as the first institution of its kind in the nation, The Wistar Institute today is a National Cancer Institute-designated Cancer Center - one of only eight focused on basic research. Discoveries at Wistar have led to the development of vaccines for such diseases as rabies and rubella, the identification of genes associated with breast, lung, and prostate cancer, and the development of monoclonal antibodies and other significant research technologies and tools.

Franklin Hoke | EurekAlert!
Further information:
http://www.wistar.upenn.edu

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data storage using individual molecules

Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.

Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Pressure tuned magnetism paves the way for novel electronic devices

18.12.2018 | Materials Sciences

New type of low-energy nanolaser that shines in all directions

18.12.2018 | Physics and Astronomy

NASA research reveals Saturn is losing its rings at 'worst-case-scenario' rate

18.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>